Gene Research, Inc., just finished a 4-year program of R&D and clinical trial. It ex- pects a quick approval from the Food and Drug Administration. If Gene markets the product its own, the company will require $30 million immediately (n = 0) to build a new manufacturing facility, and it is expected to have a 10-year product life. The R&D expenditure in the previous years and the anticipated revenues that the company can generate over the next 10 years are summarized as follows: Cash Flow (Unit: $ million) Period (n) -4 -$10 -3 -10 -2 -10 -1 -10 -10 – 30 1–10 100 Merck, a large drug company is interested, in purchasing the R&D project and the right to commercialize the product from Gene Research, Inc.; it wants to do so immediately (n = 0). What would be a starting negotiating price for the project from Merck? Assume that Gene's MARR = 20%.

Essentials Of Investments
11th Edition
ISBN:9781260013924
Author:Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Publisher:Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Chapter1: Investments: Background And Issues
Section: Chapter Questions
Problem 1PS
icon
Related questions
Question

q5.20

5.20 Gene Research, Inc., just finished a 4-year program of R&D and clinical trial. It ex-
pects a quick approval from the Food and Drug Administration. If Gene markets
the product its own, the company will require $30 million immediately (n = 0) to
build a new manufacturing facility, and it is expected to have a 10-year product life.
The R&D expenditure in the previous years and the anticipated revenues that the
company can generate over the next 10 years are summarized as follows:
Cash Flow
Period (n)
(Unit: $ million)
-4
-$10
-3
-10
-2
-10
-1
-10
-10 – 30
1–10
100
Merck, a large drug company is interested, in purchasing the R&D project and the
right to commercialize the product from Gene Research, Inc.; it wants to do so
immediately (n = 0). What would be a starting negotiating price for the project
from Merck? Assume that Gene's MARR = 20%.
Transcribed Image Text:5.20 Gene Research, Inc., just finished a 4-year program of R&D and clinical trial. It ex- pects a quick approval from the Food and Drug Administration. If Gene markets the product its own, the company will require $30 million immediately (n = 0) to build a new manufacturing facility, and it is expected to have a 10-year product life. The R&D expenditure in the previous years and the anticipated revenues that the company can generate over the next 10 years are summarized as follows: Cash Flow Period (n) (Unit: $ million) -4 -$10 -3 -10 -2 -10 -1 -10 -10 – 30 1–10 100 Merck, a large drug company is interested, in purchasing the R&D project and the right to commercialize the product from Gene Research, Inc.; it wants to do so immediately (n = 0). What would be a starting negotiating price for the project from Merck? Assume that Gene's MARR = 20%.
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 2 steps with 2 images

Blurred answer
Knowledge Booster
Accounting for Financial Instruments
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, finance and related others by exploring similar questions and additional content below.
Recommended textbooks for you
Essentials Of Investments
Essentials Of Investments
Finance
ISBN:
9781260013924
Author:
Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Publisher:
Mcgraw-hill Education,
FUNDAMENTALS OF CORPORATE FINANCE
FUNDAMENTALS OF CORPORATE FINANCE
Finance
ISBN:
9781260013962
Author:
BREALEY
Publisher:
RENT MCG
Financial Management: Theory & Practice
Financial Management: Theory & Practice
Finance
ISBN:
9781337909730
Author:
Brigham
Publisher:
Cengage
Foundations Of Finance
Foundations Of Finance
Finance
ISBN:
9780134897264
Author:
KEOWN, Arthur J., Martin, John D., PETTY, J. William
Publisher:
Pearson,
Fundamentals of Financial Management (MindTap Cou…
Fundamentals of Financial Management (MindTap Cou…
Finance
ISBN:
9781337395250
Author:
Eugene F. Brigham, Joel F. Houston
Publisher:
Cengage Learning
Corporate Finance (The Mcgraw-hill/Irwin Series i…
Corporate Finance (The Mcgraw-hill/Irwin Series i…
Finance
ISBN:
9780077861759
Author:
Stephen A. Ross Franco Modigliani Professor of Financial Economics Professor, Randolph W Westerfield Robert R. Dockson Deans Chair in Bus. Admin., Jeffrey Jaffe, Bradford D Jordan Professor
Publisher:
McGraw-Hill Education